StockGlow

Pasithea Therapeutics Corp. (KTTAW)

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

$0.01+0.00%
Compare KTTAW with
StockGlow Score
0
Bearish
BearishBullish
1 year ago-13.8%

The outlook

Pasithea Therapeutics Corp. currently reads as bearish based on 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

52-week range0% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.01
52-wk low
$0.01
50-day avg
—
200-day avg
—
Trailing P/E
—

Similar stocks

KTTAPasithea Therapeutics Corp.$0.44-0.07%BFRIWBiofrontera Inc.$0.03+0.00%DRMAWDermata Therapeutics, Inc.$0.01+0.00%REVBWRevelation Biosciences, Inc.$0.01+0.00%JSPRWJasper Therapeutics, Inc.$0.01+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy